相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Waleed Haso et al.
BLOOD (2013)
Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome
Franziska Meyr et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
The impact of trisomy 21 on early human hematopoiesis
Anindita Roy et al.
CELL CYCLE (2013)
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial
Ajay Vora et al.
LANCET ONCOLOGY (2013)
Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia
C. Bohnstedt et al.
LEUKEMIA (2013)
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
Max S. Topp et al.
BLOOD (2012)
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Ching-Hon Pui et al.
BLOOD (2012)
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia
Shannon L. Maude et al.
BLOOD (2012)
DYRK1A in Down syndrome: an oncogene or tumor suppressor?
Yehudit Birger et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
T. D. Buitenkamp et al.
LEUKEMIA (2012)
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21
Anindita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Yousif Matloub et al.
BLOOD (2011)
Infections and immunodeficiency in Down syndrome
G. Ram et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Acute lymphoblastic leukemia and Down syndrome: the collaborative study of the Tokyo Children's Cancer Study Group and the Kyushu Yamaguchi Children's Cancer Study Group
Hiroaki Goto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Targeted Therapy With the T-Cell-Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
Max S. Topp et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
Chen Shochat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Decreased Thymic Output Accounts for Decreased Naive T Cell Numbers in Children with Down Syndrome
Beatrijs L. P. Bloemers et al.
JOURNAL OF IMMUNOLOGY (2011)
Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia
R. Handgretinger et al.
LEUKEMIA (2011)
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
Libi Hertzberg et al.
BLOOD (2010)
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group
Kelly W. Maloney et al.
BLOOD (2010)
Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia
Trudy D. Buitenkamp et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome
S. Cetiner et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2010)
Both Normal Memory Counts and Decreased Naive Cells Favor Intrinsic Defect Over Early Senescence of Down Syndrome T Lymphocytes
Maaike A. A. Kusters et al.
PEDIATRIC RESEARCH (2010)
Down Syndrome B-Lymphocyte Subpopulations, Intrinsic Defect or Decreased T-Lymphocyte Help
Ruud H. J. Verstegen et al.
PEDIATRIC RESEARCH (2010)
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
Akinori Yoda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
Sebastien Malinge et al.
BLOOD (2009)
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
Lisa J. Russell et al.
BLOOD (2009)
Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia
Amos Gaikwad et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Intrinsic defect of the immune system in children with Down syndrome: a review
M. A. A. Kusters et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Poor Treatment Compliance in Children With Down Syndrome and Acute Lymphoblastic Leukemia
Catherine Bohnstedt et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia
Charles G. Mullighan et al.
NATURE GENETICS (2009)
Outcome and Toxicity of Chemotherapy for Acute Lymphoblastic Leukemia in Children With Down Syndrome
Niketa Shah et al.
PEDIATRIC BLOOD & CANCER (2009)
Acute lymphoblastic leukemia and Down syndrome - Presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
Maurizio Arico et al.
CANCER (2008)
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Dani Bercovich et al.
LANCET (2008)
Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome:: an iBFM-SG study
Erik Forestier et al.
BLOOD (2008)
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia
B. Meissner et al.
BONE MARROW TRANSPLANTATION (2007)
Age-dependent deficiency in saliva and salivary antibodies secretion in Down's syndrome
S. Chaushu et al.
ARCHIVES OF ORAL BIOLOGY (2007)
Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia
Sebastien Malinge et al.
BLOOD (2007)
Down syndrome and acute lymphoblastic leukaemia
James A. Whitlock
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients
B. T. Costa-Carvalho et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Joseph R. Arron et al.
NATURE (2006)
Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study
JA Whitlock et al.
BLOOD (2005)
Intrinsic abnormalities of lymphocyte counts in children with Down syndrome
YCM De Hingh et al.
JOURNAL OF PEDIATRICS (2005)
Acute leukaemia in children with Down syndrome: a population-based Nordic study
B Zeller et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Down syndrome, drug metabolism, and chromosome 21
JW Taub et al.
PEDIATRIC BLOOD & CANCER (2005)
Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952
M Bassal et al.
PEDIATRIC BLOOD & CANCER (2005)
Immunogenicity and safety of an inactivated hepatitis A vaccine in children with Down syndrome
CT Ferreira et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome
CM Zwaan et al.
BLOOD (2002)
Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment
JM Chessells et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2001)
Pattern of malignant disorders in individuals with Down's syndrome
Henrik Hasle
LANCET ONCOLOGY (2001)
Risks of leukaemia and solid tumours in individuals with Down's syndrome
H Hasle et al.
LANCET (2000)
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome
B Lange
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
